Replies to post #565826 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

DCVax-L treatment arm got double dosing regimen, other trials didn't.

False. Read the SAP. The questioning of the SAP is moot as we have already seen a RA approve a pediatric trial using the same design. Ultimately, the opinion of the RA is all that matters.

[biosectinvestor]

Your concepts here are false and you seem not to understand that “double dosing” is not an actual thing.

Patients already on DCVax-L don’t cross over. They just continue treatment. That is not “double dosing”. This is a nonsense concept you manufactured.